Good evening :)
Place Order
Add to Watchlist
Home
Portfolio
Search
GoldGold
More

Natural Capsules Ltd

NATCAPSUQ

Natural Capsules Ltd

NATCAPSUQ
Health CarePharmaceuticals
SmallcapWith a market cap of ₹294 cr, stock is ranked 2,222
Moderate RiskStock is 2.82x as volatile as Nifty
281.501.57% (-4.50)
281.501.57% (-4.50)

Price Chart

High
—
Low
—
Returns
—
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Health CarePharmaceuticals
SmallcapWith a market cap of ₹294 cr, stock is ranked 2,222
Moderate RiskStock is 2.82x as volatile as Nifty
Scorecard

Performance

Low

Hasn't fared well - amongst the low performers

Valuation

High

Seems to be overvalued vs the market average

Growth

Low

Lagging behind the market in financials growth

Profitability

Avg

Average profitability - not good, not bad

Entry point

Good

The stock is underpriced and is not in the overbought zone

Red flags

Low

No red flag found

How to use scorecard? Learn more

Health CarePharmaceuticals
SmallcapWith a market cap of ₹294 cr, stock is ranked 2,222
Moderate RiskStock is 2.82x as volatile as Nifty

Key Metrics

No LabelNo LabelPB RatioPB RatioDividend YieldDiv. Yield
132.381.26—
Sector PESector PESector PBSector PBSector Div YldSctr Div Yld
51.926.650.51%

Forecast & Ratings

Detailed Forecast 
—
Forecast data is currently unavailable for this stock

Price

Price Upside

Earnings

Earnings Growth

Revenue

Rev. Growth

See Detailed Forecast

Company Profile

Natural Capsules Limited makes hard gelatin capsule shells, hard cellulose capsule shells and pharmaceutical dosage forms in capsule dosage form.

Peers

Compare with peers 
Compare with Peers

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

Forecasts

Price

Revenue

Earnings

Price Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Revenue Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Earnings Per Share Forecast

Hmm, looks like data is unavailable here. Please come back after some time

Income

Balance Sheet

Cash Flow

Income Statement

Industry refers to the sub-sector this company belongs to.

Higher than Industry Revenue Growth

A higher-than-industry revenue growth represents increased potential for the company to increase their market share

Over the last 5 years, revenue has grown at a yearly rate of 20.9%, vs industry avg of 9.03%

Increasing Market Share

Market share is the percentage of an industry's total sales going to a particular company. It gives a general idea of the size of a company v/s its competitors

Over the last 5 years, market share increased from 0.03% to 0.04%

Higher than Industry Net Income

Net income is equal to net earnings (profit) less expenses. This number is an important measure of how profitable the company is

Over the last 5 years, net income has grown at a yearly rate of 23.57%, vs industry avg of 15.27%

Loading...

Financial YearFY 2018FY 2019FY 2020FY 2021FY 2022FY 2023FY 2024TTM
Total Revenue55.5760.9262.5082.42136.08172.94157.36162.32
Raw Materialssubtract23.5422.8027.9236.1057.9983.8685.48142.91
Power & Fuel Costsubtract6.798.898.168.5111.9013.7515.19
Employee Costsubtract5.235.575.916.978.489.5111.00
Selling & Administrative Expensessubtract9.478.898.999.7616.9523.0017.80
Operating & Other expensessubtract4.198.975.137.0814.256.895.89
Depreciation/Amortizationsubtract4.333.204.124.315.047.218.679.02
Interest & Other Itemssubtract0.330.530.910.542.083.735.275.78
Taxes & Other Itemssubtract0.570.140.522.245.476.552.502.44
EPS1.472.541.119.0919.0522.645.972.32
DPS0.820.820.490.821.001.000.000.00
Payout ratio0.560.320.450.090.050.040.000.00
See Costs

EPS and DPS in ₹. Other numbers except Payout Ratio in ₹ cr

Company Updates

Annual Report and Investor Presentation updates mentioned here are as reported by the company to the exchange
FY 2016

Annual report

PDF
FY 2017

Annual report

PDF
FY 2018

Annual report

PDF
FY 2019

Annual report

PDF
FY 2020

Annual report

PDF
FY 2021

Annual report

PDF
FY 2022

Annual report

PDF

Investor Presentation

Nov 1PDF
FY 2023

Annual report

PDF

Investor Presentation

May 28PDF
Oct 28PDF
FY 2024

Annual report

PDF
 

Peers & Comparison

Comparing 3 stocks from 
Health CarePharmaceuticals

Valuation

Technical

Forecast

ScreenerCompare valuation on Screener

Loading...

StockPE RatioPE RatioPB RatioPB RatioDiv. YieldDividend Yield
Natural Capsules Ltd51.671.26—
Sun Pharmaceutical Industries Ltd45.126.440.75%
Cipla Ltd28.854.440.88%
Torrent Pharmaceuticals Ltd69.1016.690.83%

Price Comparison

Compare NATCAPSUQ with any stock or ETF
Compare NATCAPSUQ with any stock or ETF
NATCAPSUQ
Loading...

Shareholdings

Promoter Holdings Trend

Decreased Total Promoter Holding

Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has decreased by 5.43%

Low Pledged Promoter Holding

Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Institutional Holdings Trend

Total Retail Holding

Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.

In last 3 months, retail holding in the company has almost stayed constant

Foreign Institutional Holding

Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock

In last 3 months, foreign institutional holding of the company has almost stayed constant

Tickertape Separator

Shareholding Pattern

Retail and OthersForeign InstitutionsOther Domestic InstitutionsMutual FundsTotal Promoter Holding51.14%0.00%0.00%0.00%48.86%

Mar 2024

Jun 2024

Sep 2024

Nov 2024

Shareholding History

SepDec '23MarJunSepNov0.00%0.00%0.00%0.00%0.00%0.00%

Insider Trades & Bulk Deals

Loading...

smallcases

Looks like this stock is not in any smallcase yet.

Events

Dividend Trend

No dividend trend available

Dividends

Corp. Actions

Announcements

Legal Orders

Upcoming Dividends

No upcoming dividends are available

Past Dividends

Cash Dividend

Ex DateEx DateJul 20, 2023

Final
Final | Div/Share: ₹1.00

Dividend/Share

₹1.00

Ex DateEx Date

Jul 20, 2023

Cash Dividend

Ex DateEx DateSep 9, 2022

Final
Final | Div/Share: ₹1.00

Dividend/Share

₹1.00

Ex DateEx Date

Sep 9, 2022

Cash Dividend

Ex DateEx DateJul 6, 2021

Final
Final | Div/Share: ₹1.00

Dividend/Share

₹1.00

Ex DateEx Date

Jul 6, 2021

Cash Dividend

Ex DateEx DateAug 12, 2020

Final
Final | Div/Share: ₹0.60

Dividend/Share

₹0.60

Ex DateEx Date

Aug 12, 2020

Cash Dividend

Ex DateEx DateAug 13, 2019

Final
Final | Div/Share: ₹1.00

Dividend/Share

₹1.00

Ex DateEx Date

Aug 13, 2019

News & Opinions
Earnings
Natural Capsules reports consolidated net loss of Rs 0.61 crore in the September 2024 quarter

Net loss of Natural Capsules reported to Rs 0.61 crore in the quarter ended September 2024 as against net profit of Rs 1.56 crore during the previous quarter ended September 2023. Sales rose 9.86% to Rs 41.22 crore in the quarter ended September 2024 as against Rs 37.52 crore during the previous quarter ended September 2023. ParticularsQuarter EndedSep. 2024Sep. 2023% Var. Sales41.2237.52 10 OPM %10.9213.65 - PBDT2.964.31 -31 PBT0.622.14 -71 NP-0.611.56 PL Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Natural Capsules to table results

Natural Capsules will hold a meeting of the Board of Directors of the Company on 12 November 2024Powered by Capital Market - Live

1 month agoCapital Market - Live
Corporate
Natural Capsules to hold board meeting

Natural Capsules will hold a meeting of the Board of Directors of the Company on 5 September 2024.Powered by Capital Market - Live

3 months agoCapital Market - Live
Earnings
Natural Capsules consolidated net profit declines 67.03% in the June 2024 quarter

Net profit of Natural Capsules declined 67.03% to Rs 0.60 crore in the quarter ended June 2024 as against Rs 1.82 crore during the previous quarter ended June 2023. Sales rose 3.93% to Rs 39.18 crore in the quarter ended June 2024 as against Rs 37.70 crore during the previous quarter ended June 2023. ParticularsQuarter EndedJun. 2024Jun. 2023% Var. Sales39.1837.70 4 OPM %11.1315.81 - PBDT3.054.80 -36 PBT0.772.69 -71 NP0.601.82 -67 Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Natural Capsules to table results

Natural Capsules will hold a meeting of the Board of Directors of the Company on 13 August 2024.Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Natural Capsules schedules EGM

Natural Capsules announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 23 August 2024 .Powered by Capital Market - Live

4 months agoCapital Market - Live
Corporate
Natural Capsules schedules board meeting

Natural Capsules will hold a meeting of the Board of Directors of the Company on 26 July 2024.Powered by Capital Market - Live

4 months agoCapital Market - Live